Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025

Rhea-AI Summary

Axogen (NASDAQ: AXGN) will report its 2025 third quarter financial results on Wednesday, October 29, 2025 before the market opens.

The company said management will host an investor conference call and webcast at 8:00 a.m. ET following the release. Phone participants may dial toll free at (877) 407-0993 or direct at (201) 689-8795. A live webcast, archived replay, and presentation slides will be available on the company’s Investors page at www.axogeninc.com.

ALACHUA, Fla. and TAMPA, Fla., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will report 2025 third quarter financial results on Wednesday, October 29, 2025, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release.

Investors interested in participating in the conference call by phone may do so by dialing toll free at (877) 407-0993 or use the direct dial-in number at (201) 689-8795. A live webcast, archived replay, and presentation slides of the event may be accessed on the Investors page of the company's website at www.axogeninc.com.

About Axogen

Axogen (AXGN) is the leading Company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or transection to peripheral nerves by providing innovative, clinically proven, and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain.

Axogen’s product portfolio includes Avance^® Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; Axoguard Nerve Connector^®, a porcine (pig) submucosa extracellular matrix (“ECM”) coaptation aid for tensionless repair of severed peripheral nerves; Axoguard Nerve Protector^®, a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while minimizing soft tissue attachments; Axoguard HA+ Nerve Protector™, a porcine submucosa ECM base layer coated with a proprietary hyaluronate-alginate gel, a next-generation technology designed to enhance nerve gliding and provide short- and long-term protection for peripheral nerve injuries; Axoguard Nerve Cap^®, a porcine submucosa ECM product used to protect a peripheral nerve end and separate the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive+ Soft Tissue Matrix™, a multi-layer amniotic membrane allograft used to protect and separate tissues in the surgical bed during the critical phase of tissue healing. The Axogen portfolio of products is available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea and several other countries.​

For more information, visit www.axogeninc.com

Contact:
Axogen, Inc.
InvestorRelations@axogeninc.com

FAQ

When will Axogen (AXGN) report Q3 2025 results?

Axogen will report Q3 2025 financial results on Wednesday, October 29, 2025 before the market opens.

What time is the Axogen (AXGN) Q3 2025 earnings call?

Management will host an investor call and webcast at 8:00 a.m. ET on October 29, 2025 following the release.

How can investors join the Axogen (AXGN) October 29, 2025 conference call?

Dial the toll-free number (877) 407-0993 or the direct dial (201) 689-8795 to join the call.

Where can I find the Axogen (AXGN) live webcast and replay for Q3 2025?

The live webcast, archived replay, and presentation slides will be available on Axogen’s Investors page at www.axogeninc.com.

Will Axogen (AXGN) provide presentation slides for the October 29, 2025 call?

Yes. Presentation slides will be posted on the company’s Investors page alongside the live webcast and replay.

Is the Axogen (AXGN) Q3 2025 release before or after market open on October 29, 2025?

The company will release Q3 2025 results before the market opens on October 29, 2025.